Ralph Henry
Fondateur chez InterveXion Therapeutics LLC
Profil
Ralph Henry is the founder of InterveXion Therapeutics LLC, which was founded in 2004.
He held the title of EVP-Corporate Development & Biopharmaceutics at the company.
Dr. Henry is currently working at The University of Arkansas as a Professor since 2005.
Postes actifs de Ralph Henry
Sociétés | Poste | Début |
---|---|---|
InterveXion Therapeutics LLC
InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Fondateur | 17/09/2009 |
The University of Arkansas | Corporate Officer/Principal | 17/09/2009 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
InterveXion Therapeutics LLC
InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Health Technology |